Asia Pacific Departmental Pacs Market
Tamanho do mercado em biliões de dólares
CAGR : %
Período de previsão |
2024 –2031 |
Tamanho do mercado (ano base ) | USD 3.19 Billion |
Tamanho do mercado ( Ano de previsão) | USD 5.19 Billion |
CAGR |
|
Principais participantes do mercado |
|
Mercado PACS Departamental, por Tipo de Produto (PACS Tradicional, PACS Especializado), Componente (Software, Serviços, Hardware), Aplicação (MRI, Tomografia Computadorizada, Radiografia Digital, Ecografia, Imagiologia Nuclear, C-Arms e Outros), Nível de Integração ( PACS Integrado, PACS Autónomo), Utilizador Final (Hospitais, Redes/Centros de Radiologia, Centros Cirúrgicos Ambulatório e Outros), Canal de Distribuição (Concursos Directos, Administradores Terceirizados e Outros) - Tendências do Sector e Previsão para 2031.
Análise e insights de mercado de PACS departamentais da APAC
O mercado departamental de PACS abrange um segmento do setor de tecnologia da informação em saúde dedicado ao armazenamento, recuperação, gestão e distribuição de dados de imagens médicas em departamentos hospitalares específicos ou especialidades médicas. O PACS é parte integrante dos fluxos de trabalho modernos de imagiologia médica, permitindo aos radiologistas, cardiologistas, oncologistas e outros especialistas armazenar e aceder digitalmente a imagens de diagnóstico, como raios X, ressonâncias magnéticas, tomografias computorizadas e ecografias. O sistema substitui a imagem tradicional baseada em filme, melhorando a eficiência, a precisão e a acessibilidade dos dados de imagem, melhorando assim os cuidados prestados aos doentes. Um PACS departamental é adaptado para satisfazer as necessidades e fluxos de trabalho exclusivos de departamentos individuais, apresentando frequentemente ferramentas e interfaces especializados que simplificam o processo de geração de imagens para práticas médicas específicas. Estes sistemas facilitam a integração perfeita com outros sistemas de informação hospitalar (HIS) e registos de saúde eletrónicos (RSE), garantindo que os dados de imagens dos pacientes estão prontamente disponíveis em todo o processo de prestação de cuidados. O mercado de PACS departamentais é impulsionado pelo volume crescente de procedimentos de imagiologia médica, pelos avanços na tecnologia de imagem, pela necessidade de maior precisão de diagnóstico e pelo impulso para a digitalização na área da saúde. Além disso, os requisitos regulamentares e a ênfase na redução dos custos dos cuidados de saúde alimentam ainda mais a adopção do PACS em ambientes departamentais. À medida que os prestadores de cuidados de saúde continuam a reconhecer o valor da gestão eficiente dos dados de imagem e da melhoria dos resultados dos doentes, o mercado departamental de PACS está preparado para um crescimento significativo.
A Data Bridge Market Research analisa que o mercado departamental de PACS deverá atingir os 5,19 mil milhões de dólares até 2031, contra 3,19 mil milhões de dólares em 2023, crescendo com um CAGR de 6,3% no período de previsão de 2024 a 2031 .
Métrica de reporte |
Detalhes |
Período de previsão |
2024 a 2031 |
Ano base |
2023 |
Anos históricos |
2022 (personalizável para 2016–2021) |
Unidades Quantitativas |
Receita em biliões de dólares |
Segmentos cobertos |
Product Type (Traditional PACS, Specialty PACS), Component (Software, Services, Hardware), Application (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Digital Radiography, Ultrasound, Nuclear Imaging, C-Arms, Others), Integration Level (Integrated PACS, Standalone PACS), End User (Hospital, Radiology Chains/Centers, Ambulatory Surgery Centers, Others), Distribution Channel (Direct Tenders, Third Party Administrators, and Others) |
Countries Covered |
China, Japan, India, South Korea, Australia, Taiwan, Singapore, Thailand, Indonesia, Malaysia, Philippines, New Zealand, Vietnam, rest of Asia-Pacific |
Market Players Covered |
FUJIFILM Corporation, GE Healthcare, Koninklijke Philips N.V., Agfa-Gevaert Group, Hyland Software Inc., Lexmark International Inc., Mach 7 Technologies Limited, Novarad Enterprise Healthcare Solutions, Reyence, Siemens (Siemens Healthcare Private Limited), Sectra AB, Softneta, SinoVision, TeleRAD Reporting Services Private Limited, and Voyager Imaging among others |
Market Definition
The departmental PACS market encompasses a segment of the healthcare information technology sector dedicated to the storage, retrieval, management, and distribution of medical imaging data within specific hospital departments or medical specialties. PACS is integral to modern medical imaging workflows, enabling radiologists, cardiologists, oncologists, and other specialists to digitally store and access diagnostic images such as X-rays, MRIs, CT scans, and ultrasounds. The system replaces traditional film-based imaging, improving efficiency, accuracy, and accessibility of imaging data, thereby enhancing patient care. A departmental PACS is tailored to meet the unique needs and workflows of individual departments, often featuring specialized tools and interfaces that streamline the imaging process for specific medical practices. These systems facilitate seamless integration with other hospital information systems (HIS) and electronic health records (EHR), ensuring that patient imaging data is readily available across the continuum of care. The market for departmental PACS is driven by the increasing volume of medical imaging procedures, advancements in imaging technology, the need for enhanced diagnostic accuracy, and the push towards digitization in healthcare. Additionally, regulatory requirements and the emphasis on reducing healthcare costs further fuel the adoption of PACS in departmental settings. As healthcare providers continue to recognize the value of efficient imaging data management and improved patient outcomes, the departmental PACS market is poised for significant growth.
Departmental PACS Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Driver
- Rising Demand for Early Disease Detection
The rising demand for early disease detection significantly drives the APAC Departmental PACS (Picture Archiving and Communication System) market, primarily because PACS technology enhances the efficiency and accuracy of diagnostic processes. Early disease detection often relies on advanced imaging techniques, which generate vast amounts of data needing efficient storage, retrieval, and analysis. PACS systems provide a digital solution to manage this data, allowing for quick and easy access to medical images and associated information. This capability is crucial for early disease detection, where timely and precise diagnosis can drastically improve patient outcomes. Also, the growing awareness and adoption of preventive healthcare measures in the APAC region have led to increased investments in healthcare infrastructure, including imaging technologies and PACS systems. Governments and healthcare organizations are prioritizing early detection programs to reduce the long-term burden of chronic diseases, further boosting the demand for robust PACS solutions. The integration of artificial intelligence (AI) and machine learning (ML) with PACS is also accelerating this trend, as these technologies enhance image analysis, improve diagnostic accuracy, and facilitate the early identification of diseases. Consequently, the escalating emphasis on early disease detection is propelling the expansion of the APAC Departmental PACS market as healthcare providers strive to adopt innovative solutions to meet the growing demand for efficient and effective diagnostic tools.
For instance,
- In November 2023, according to an article published in the journal Radiology Oncology Systems, PACS explored diagnostic imaging equipment’s pivotal role in identifying diseases at their earliest stages. Diagnostic imaging techniques such as X-rays, CT scans, PET scans, MRIs, and ultrasounds remain the frontline defenders against hidden health threats. They enable healthcare professionals to peer inside the body, unveiling anomalies, often before symptoms surface. In a recent study, it was revealed that early diagnosis through diagnostic imaging led to an approximately 20% increase in the effectiveness of cancer treatment options for lung cancer (American Association for Cancer Research). PACS plays a vital role in the prevention and treatment of disease
- In November 2022, according to an article published in GE HealthCare, when patients are disadvantaged from achieving their full health potential, health inequities are reflected in differences in length of life, quality of life, rates of disease, disability, and death, severity of disease, and access to treatment. The inability to access important components in the care path, such as medical imaging, can have a dramatic effect on health outcomes. Advanced medical imaging systems like PACS are needed to focus on the early diagnosis of non-communicable or chronic diseases, such as cardiovascular diseases, chronic respiratory diseases, and diabetes. Early Diagnosis is necessary to avoid further illness and wrong treatment and expenditure.
- In August 2020, according to the report published by EIT Health, new healthcare technologies like PACS constantly developed at a rapid pace and allowed for detection and diagnosis of diseases at an earlier stage. This trend, also known as early diagnostics, is expected to lead to significant change within healthcare systems as the way that diseases are found and treated are set to be reshaped. It has the potential to improve the quality of care, lower costs and provide treatment at an earlier time. Reducing downstream treatment costs for payers and society, lowering hospitalization rates and pressure on hospitals and clinicians, prescribing the right treatment for a patient, avoiding unnecessary intervention
The growing focus on early disease detection is a significant driver of the APAC Departmental PACS market because PACS technology streamlines the management of vast imaging data, which is crucial for timely and accurate diagnoses. As preventive healthcare gains traction in the region, investments in PACS systems increase, supported by the integration of AI and ML for enhanced diagnostic precision. This trend underscores the critical role of PACS in meeting the rising demand for effective diagnostic tools, thereby fostering market growth.
Restraint
- High Costs Associated with the Implementation of Medical Imaging Management
Os elevados custos associados à implementação de sistemas de gestão de imagens médicas, como o PACS (Picture Archiving and Communication Systems), funcionam como uma restrição significativa para o mercado de PACS departamentais da APAC. Estes custos abrangem não só o investimento inicial em hardware e software sofisticados, mas também as despesas contínuas relacionadas com a manutenção do sistema, actualizações e formação do pessoal médico. As instalações de saúde mais pequenas e as localizadas em regiões em desenvolvimento no mercado da APAC enfrentam frequentemente restrições orçamentais, tornando difícil alocar fundos suficientes para estas soluções avançadas de gestão de imagens. Além disso, o encargo financeiro da integração do PACS com os sistemas de informação hospitalar existentes e da garantia da segurança dos dados e da conformidade com os regulamentos de saúde aumenta o custo global. Estes desafios económicos podem dissuadir os prestadores de cuidados de saúde de adoptarem a tecnologia PACS, apesar dos seus benefícios no aumento da precisão do diagnóstico e da eficiência operacional. Como resultado, o crescimento do mercado de PACS na região da APAC pode ser dificultado, particularmente em áreas menos ricas, onde os elevados custos de implementação e manutenção apresentam uma barreira significativa à adoção.
Por exemplo,
- Em abril de 2024, de acordo com um artigo da Appinventiv, um dos maiores fornecedores de serviços de TI do mundo, o custo médio de desenvolvimento de software de imagiologia médica PACS e DICOM variou entre 30.000 e 300.000 dólares. Este custo foi afetado por fatores como a complexidade do software, os prazos de entrega, a localização da empresa de desenvolvimento de software contratada, a conformidade com as normas regulamentares como a HIPAA e o nível de especialização exigido à equipa de desenvolvimento. Isto funcionou como contenção e dificultou o crescimento do mercado
- Em novembro de 2019, o PACS representou um investimento significativo, uma vez que era uma aplicação de software separada que tinha de ser adquirida independentemente do Vendor Neutral Archive (VNA) existente e dos visualizadores DICOM. Durante os desenvolvimentos recentes, o PACS teve custos elevados, o que se tornou uma restrição significativa no mercado de dispositivos médicos. Além disso, a integração de um VNA numa configuração PACS existente poderia envolver despesas adicionais substanciais, aumentando ainda mais a carga financeira e atuando como uma restrição ao crescimento do mercado
Os elevados custos de implementação de sistemas de gestão de imagens médicas, incluindo PACS, funcionam como uma restrição significativa para o mercado de PACS departamentais da APAC. Estas despesas, que cobrem investimentos iniciais, manutenção contínua, atualizações de sistemas e formação de pessoal, podem ser proibitivas para unidades de saúde de menor dimensão ou com orçamento limitado. O encargo financeiro da integração do PACS com os sistemas existentes e da garantia da conformidade regulamentar agrava ainda mais este desafio. Como resultado, estes custos elevados podem limitar a adopção da tecnologia PACS, particularmente em regiões menos ricas, e impedir o crescimento do mercado.
Oportunidade
- Adoção de tecnologia de IA em imagens
A adoção da tecnologia de IA em imagens apresenta oportunidades significativas para o mercado PACS departamental (sistemas de comunicação e arquivo de imagens) da APAC, melhorando a precisão do diagnóstico, a eficiência e a automatização do fluxo de trabalho. Os algoritmos alimentados por IA podem analisar imagens médicas com alta precisão, auxiliando os radiologistas na deteção de anomalias, no diagnóstico de condições e na priorização de casos urgentes de forma mais eficaz. Esta integração agiliza o processo de geração de imagens, reduzindo o tempo necessário para a análise e interpretação de imagens, o que é crucial em ambientes de grande volume. A IA melhora a funcionalidade dos sistemas PACS, permitindo funcionalidades avançadas, como a segmentação automatizada de imagens, a análise preditiva e as ferramentas de apoio à decisão, que melhoram os resultados clínicos globais. À medida que os prestadores de cuidados de saúde na região da APAC procuram cada vez mais aproveitar a IA para gerir o volume crescente de imagens médicas e otimizar os fluxos de trabalho de diagnóstico, espera-se que a procura por sistemas PACS que incorporem estas tecnologias avançadas aumente. Esta mudança não só posiciona os sistemas PACS como componentes integrantes da infra-estrutura moderna de saúde, como também abre novos caminhos para a inovação e o crescimento do mercado na região da APAC.
Por exemplo,
- Em junho de 2024, de acordo com uma notícia publicada pelo MIT news, mencionando que a inteligência artificial e o PACS desempenham frequentemente um papel nos diagnósticos médicos, especialmente quando se trata de análise de imagens como os raios X. Estes modelos também demonstraram desenvolver algumas capacidades surpreendentes. Em 2022, os investigadores do MIT relataram que os modelos de IA esperarão fazer previsões precisas sobre a raça de um paciente a partir das suas radiografias torácicas. A sua equipa de investigação descobriu agora que os modelos mais precisos para fazer previsões demográficas
- Em junho de 2024, de acordo com uma notícia publicada pelo MIT news, dando conta que, em maio de 2024, a FDA aprovou 882 dispositivos médicos habilitados para IA, sendo que 671 deles foram concebidos para utilização em radiologia. Desde 2022, quando Ghassemi e os seus colegas mostraram que estes modelos de diagnóstico podem prever a raça com precisão, eles e outros investigadores mostraram que tais modelos também são muito bons a prever o género e a idade, embora os modelos não sejam treinados nestas tarefas.
- Em março de 2024, de acordo com um artigo publicado pela Elsevier, destacando os domínios da IA, como a análise melhorada de imagens, a eficiência operacional, os cuidados de saúde preditivos e personalizados e o apoio à decisão clínica no diagnóstico por imagem. Concluiu que a IA está a revolucionar o diagnóstico por imagem, melhorando a precisão, a eficiência e a prestação de cuidados de saúde personalizados
- Em abril de 2024, conforme artigo publicado pela Elsevier, com o objetivo de mapear os instrumentos tecnológicos disponíveis para melhorar o acesso à imagem nos cuidados de saúde primários; identificar os facilitadores e as barreiras e as lacunas de conhecimento para a adaptação generalizada das soluções tecnológicas. Sugere que a telerradiologia, quando combinada com a IA e as unidades móveis de imagiologia digital, pode colmatar a escassez de radiologistas; fortalecer os programas destinados à triagem populacional e atendimento emergencial
A adoção da tecnologia de IA em imagens cria oportunidades substanciais para o mercado PACS departamental da APAC, melhorando a precisão do diagnóstico e a eficiência do fluxo de trabalho. A IA permite funcionalidades avançadas como a análise automatizada de imagens e análises preditivas, que agilizam o processo de geração de imagens e melhoram os resultados clínicos. À medida que os prestadores de cuidados de saúde na APAC integram cada vez mais a IA para lidar com as crescentes exigências de imagiologia, espera-se que a necessidade de sistemas PACS avançados aumente, impulsionando o crescimento e a inovação do mercado.
Desafio
- Preocupações com a segurança e privacidade dos dados devido à complexidade técnica
Os sistemas de arquivo e comunicação de imagens (PACS) são tecnologias sofisticadas que requerem conhecimentos informáticos avançados para instalação, configuração e manutenção. As exigências técnicas associadas a estes sistemas podem levar a custos operacionais substanciais e a desafios de alocação de recursos. Garantir a fiabilidade do sistema e minimizar o tempo de inatividade é essencial, uma vez que interrupções como falhas do sistema, perda de dados ou falhas de software podem atrasar o acesso a imagens médicas críticas, o que, por sua vez, afeta a precisão do diagnóstico e a oportunidade do tratamento. A necessidade de suporte informático especializado para a resolução de problemas e atualizações contínuas do sistema complica ainda mais e aumenta o custo de manutenção destes sistemas.
Por exemplo,
- Em dezembro de 2020, de acordo com um artigo publicado pelo NIST, a proteção do PACS era um desafio devido às diversas necessidades de imagiologia médica em diferentes departamentos das organizações de saúde (HDOs) e à utilização de vários PACS ou sistemas de arquivo. Além disso, estiveram envolvidos especialistas externos em imagiologia e vários utilizadores clínicos acederam ao PACS a partir de diferentes locais, criando um ambiente complexo que aumentou os riscos de cibersegurança
- Esta complexidade representou um desafio para o mercado PACS departamental da Ásia-Pacífico, tornando difícil garantir medidas robustas de cibersegurança num ecossistema PACS fragmentado e amplamente acedido
- De acordo com um artigo publicado pela Open MedScience, os sistemas PACS dependem de tecnologia complexa, o que pode levar a problemas como falhas de sistema, perda de dados e falhas de software, causando tempos de inatividade e atrasos no atendimento ao paciente. Além disso, o PACS exige formação especializada e, muitas vezes, dispendiosa para a equipa de radiologia, sendo necessárias atualizações contínuas para acompanhar os avanços tecnológicos. Este desafio impacta o Mercado PACS Departamental da Ásia-Pacífico, aumentando os custos operacionais e potencialmente interrompendo o atendimento ao paciente devido a questões técnicas e à necessidade de formação contínua da equipa
A complexidade técnica aumenta as preocupações sobre a segurança e a privacidade dos dados, uma vez que a gestão e a proteção de informações médicas sensíveis em sistemas diversos e intrincados podem ser particularmente desafiantes, afetando a eficiência e a segurança globais das instalações de saúde.
Desenvolvimentos recentes
- Em janeiro de 2024, a FUJIFILM Diosynth Biotechnologies e a SHL Medical assinaram um acordo de parceria estratégica para ajudar a satisfazer a crescente procura do mercado por medicamentos autoinjetores. A parceria, parte do Programa de Gestão de Alianças da SHL, teve como objetivo agilizar os processos e aumentar a eficiência para as empresas farmacêuticas e de biotecnologia que oferecem serviços de produtos acabados para dispositivos de autoinjeção, principalmente com a principal plataforma da SHL, a Molly
- Em agosto de 2022, o Grupo Agfa-Gevaert assinou um acordo de compra de ações com o Grupo AURELIUS para a venda da sua divisão Offset Solutions no âmbito do seu processo de transformação em curso. As vendas permitiram ao Grupo aumentar o foco nos seus negócios de crescimento
Âmbito de mercado PACS departamental
O mercado departamental de PACS está segmentado em seis segmentos notáveis com base no Tipo de Produto, Componente, Aplicação, Nível de Integração, Utilizador Final, Canal de Distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e as diferenças nos seus mercados-alvo.
Por tipo de produto (PACS tradicional, PACS especializado), componente (software, serviços, hardware), aplicação (ressonância magnética (RM), tomografia computorizada (TC), radiografia digital, ecografia, imagem nuclear, arcos cirúrgicos, outros), Nível de Integração (PACS Integrado, PACS Autónomo), Utilizador Final (Hospital, Redes/Centros de Radiologia, Centros de Cirurgia Ambulatória, Outros), Canal de Distribuição (Concursos Diretos, Administradores Terceirizados, Outros)
Tipo de produto
- PACS tradicionais
- PACS Especializados
Com base no tipo de produto, o mercado está segmentado em PACS tradicionais e PACS especiais.
Componente
- Software
- Serviços
- Hardware
Com base no componente, o mercado está segmentado em software, serviços e hardware.
Aplicação
- Imagem por ressonância magnética (RM)
- Tomografia Computadorizada (TC)
- Radiografia Digital
- Ultrassom
- Imagem Nuclear
- Braços em C
- Outros
On the basis of application, the market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), digital radiography, ultrasound, nuclear imaging, c-arms, and others.
Integration Level
- Integrated PACS
- Standalone PACS
On the basis of integration level, the market is segmented into integrated PACS, and standalone PACS.
End User
- Hospitals
- Radiology Chains/Centers,
- Ambulatory Surgical Centers
- Others
On the basis of end user, the market is segmented into hospitals, radiology chains/centers, ambulatory surgical centers, and others.
Distribution Channel
- Direct Tenders
- Third Party Administrators
- Others
On the basis of distribution channel, the market is segmented into direct tenders, third party administrators, and others.
Departmental PACS Market Regional Analysis/Insights
The departmental PACS market is segmented into nine notable segments based on Product Type, Component, Application, Integration Level, End User, and Distribution Channel.
The countries covered in this market report are China, Japan, India, South Korea, Australia, Taiwan, Singapore, Thailand, Indonesia, Malaysia, Philippines, New Zealand, Vietnam, rest of Asia-Pacific.
Japan is growing in the APAC departmental PACS market and is expected to dominate the market with an increasing prevalence of chronic disorders in the country.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and APAC Departmental PACS Market Share Analysis
The departmental PACS market competitive landscape provides details of competitors. Details included are compmarketany overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players are FUJIFILM Corporation, GE Healthcare, Koninklijke Philips N.V., Agfa-Gevaert Group, Hyland Software Inc., Lexmark International Inc., Mach 7 Technologies Limited, Novarad Enterprise Healthcare Solutions, Reyence, Siemens (Siemens Healthcare Private Limited), Sectra AB, Softneta, SinoVision, TeleRAD Reporting Services Private Limited, and Voyager Imaging among others.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING DEMAND FOR EARLY DISEASE DETECTION
6.1.2 INCREASING IMAGING EQUIPMENT USAGE
6.1.3 THE PREVALENCE OF CHRONIC DISEASE AND PAIN-RELATED CONDITIONS
6.1.4 RISE IN BONE INJURIES AND ORTHOPEDIC CONDITIONS AND ITS IMAGING
6.2 RESTRAINTS
6.2.1 HIGH COSTS ASSOCIATED WITH THE IMPLEMENTATION OF MEDICAL IMAGING MANAGEMENT
6.2.2 STRINGENT REGULATORY REQUIREMENTS INVOLVED IN THE MANAGEMENT PROCESS
6.3 OPPORTUNITIES
6.3.1 ADOPTION OF AI TECHNOLOGY IN IMAGING
6.3.2 IMPROVEMENT IN GOVERNMENTAL STANDARDS AND POLICIES
6.3.3 ADVANCEMENTS IN RESEARCH AND DEVELOPMENT
6.4 CHALLENGES
6.4.1 DATA SECURITY AND PRIVACY CONCERNS DUE TO TECHNICAL COMPLEXITY
6.4.2 INCREASING IN THE INTEROPERABILITY ISSUES
7 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 TRADITIONAL PACS
7.2.1 IMAGE PROCESSING
7.2.2 IMAGE MANAGEMENT
7.3 SPECIALITY PACS
7.3.1 CARDIOLOGY PACS
7.3.2 ONCOLOGY PACS
7.3.3 PATHOLOGY PACS
7.3.4 ORTHOPEDIC PACS
7.3.5 DERMATOLOGY PACS
7.3.6 OPTHALMOLOGY PACS
7.3.7 DENTAL PACS
7.3.8 VETERINARY PACS
7.3.9 OTHERS
8 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COMPONENT
8.1 OVERVIEW
8.2 SOFTWARE
8.2.1 WEB/ CLOUD BASED
8.2.2 ON PREMISES
8.2.3 HYBRID
8.3 SERVICES
8.4 HARDWARE
9 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 MAGNETIC RESONANCE IMAGING (MRI)
9.3 COMPUTED TOMOGRAPHY (CT)
9.4 DIGITAL RADIOGRAPHY
9.5 ULTRASOUND
9.6 NUCLEAR IMAGING
9.7 C-ARMS
9.8 OTHERS
10 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL
10.1 OVERVIEW
10.2 INTEGRATED PACS
10.3 STANDALONE PACS
11 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.2.1 BY TYPE
11.2.1.1 LARGE HOSPITALS
11.2.1.2 MEDIUM-SIZED HOSPITALS
11.2.1.3 SMALL HOSPITALS
11.3 RADIOLOGY CHAINS/ CENTERS
11.4 AMBULATORY SURGERY CENTERS
11.5 OTHERS
12 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDERS
12.3 THIRD PARTY ADMINISTRATORS
12.4 OTHERS
13 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COUNTRY
13.1 ASIA-PACIFIC
13.1.1 JAPAN
13.1.2 CHINA
13.1.3 AUSTRALIA
13.1.4 INDIA
13.1.5 SOUTH KOREA
13.1.6 SINGAPORE
13.1.7 MALAYSIA
13.1.8 THAILAND
13.1.9 INDONESIA
13.1.10 VIETNAM
13.1.11 PHILIPPINES
13.1.12 REST OF ASIA-PACIFIC
14 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 FUJIFILM CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENT
16.2 GE HEALTHCARE
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 KONINKLIJKE PHILIPS N.V.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 AGFA-GEVAERT GROUP.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 HYLAND SOFTWARE, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 PRODUCT PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 LEXMARK INTERNATIONAL, INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 MACH 7 TECHNOLOGIES LIMITED
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 NOVARAD ENTERPRISE HEALTHCARE SOLUTIONS
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 RAYENCE
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 SIEMENS (SIEMENS HEALTHCARE PRIVATE LIMITED)
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 SECTRA AB
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 SOFTNETA
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 SINOVISION
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 TELERAD REPORTING SERVICES PRIVATE LIMITED
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 VOYAGER IMAGING
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tabela
TABLE 1 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC (APAC) TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC (APAC) IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC (APAC) SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC (APAC) CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC (APAC) ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC (APAC) ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC (APAC) DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC (APAC) OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC (APAC) VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC (APAC) TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 20 JAPAN DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 21 JAPAN TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 22 JAPAN IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 JAPAN SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 24 JAPAN CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 25 JAPAN ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 26 JAPAN ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 27 JAPAN DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 28 JAPAN OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 29 JAPAN DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 30 JAPAN VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 31 JAPAN DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 32 JAPAN SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 33 JAPAN DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 34 JAPAN DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 35 JAPAN DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 36 JAPAN HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 JAPAN DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 38 CHINA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 CHINA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 40 CHINA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 41 CHINA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 CHINA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 43 CHINA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 44 CHINA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 45 CHINA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 46 CHINA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 47 CHINA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 48 CHINA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 49 CHINA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 50 CHINA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 51 CHINA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 52 CHINA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 53 CHINA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 54 CHINA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 55 CHINA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 56 AUSTRALIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 AUSTRALIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 58 AUSTRALIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 AUSTRALIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 AUSTRALIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 61 AUSTRALIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 62 AUSTRALIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 63 AUSTRALIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 64 AUSTRALIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 65 AUSTRALIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 66 AUSTRALIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 67 AUSTRALIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 68 AUSTRALIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 AUSTRALIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 70 AUSTRALIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 71 AUSTRALIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 72 AUSTRALIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 AUSTRALIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 74 INDIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 INDIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 76 INDIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 INDIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 78 INDIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 79 INDIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 80 INDIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 81 INDIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 82 INDIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 83 INDIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 84 INDIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 85 INDIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 86 INDIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 INDIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 88 INDIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 89 INDIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 90 INDIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 91 INDIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 92 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 SOUTH KOREA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 94 SOUTH KOREA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 SOUTH KOREA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 SOUTH KOREA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 97 SOUTH KOREA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 98 SOUTH KOREA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 99 SOUTH KOREA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 100 SOUTH KOREA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 101 SOUTH KOREA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 102 SOUTH KOREA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 103 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 104 SOUTH KOREA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 106 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 107 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 108 SOUTH KOREA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 110 SINGAPORE DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 SINGAPORE TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 112 SINGAPORE IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 113 SINGAPORE SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 114 SINGAPORE CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 115 SINGAPORE ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 116 SINGAPORE ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 117 SINGAPORE DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 118 SINGAPORE OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 119 SINGAPORE DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 120 SINGAPORE VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 121 SINGAPORE DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 122 SINGAPORE SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 SINGAPORE DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 124 SINGAPORE DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 125 SINGAPORE DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 126 SINGAPORE HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 127 SINGAPORE DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 128 MALAYSIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 MALAYSIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 130 MALAYSIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 MALAYSIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 MALAYSIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 133 MALAYSIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 134 MALAYSIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 135 MALAYSIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 136 MALAYSIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 137 MALAYSIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 138 MALAYSIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 139 MALAYSIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 140 MALAYSIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 MALAYSIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 142 MALAYSIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 143 MALAYSIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 144 MALAYSIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 MALAYSIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 146 THAILAND DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 THAILAND TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 148 THAILAND IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 THAILAND SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 150 THAILAND CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 151 THAILAND ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 152 THAILAND ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 153 THAILAND DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 154 THAILAND OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 155 THAILAND DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 156 THAILAND VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 157 THAILAND DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 158 THAILAND SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 THAILAND DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 160 THAILAND DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 161 THAILAND DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 162 THAILAND HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 163 THAILAND DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 164 INDONESIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 INDONESIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 166 INDONESIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 167 INDONESIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 INDONESIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 169 INDONESIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 170 INDONESIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 171 INDONESIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 172 INDONESIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 173 INDONESIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 174 INDONESIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 175 INDONESIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 176 INDONESIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 INDONESIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 178 INDONESIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 179 INDONESIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 180 INDONESIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 INDONESIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 182 VIETNAM DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 VIETNAM TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 184 VIETNAM IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 VIETNAM SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 VIETNAM CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 187 VIETNAM ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 188 VIETNAM ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 189 VIETNAM DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 190 VIETNAM OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 191 VIETNAM DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 192 VIETNAM VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 193 VIETNAM DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 194 VIETNAM SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 VIETNAM DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 196 VIETNAM DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 197 VIETNAM DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 198 VIETNAM HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 VIETNAM DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 200 PHILIPPINES DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 201 PHILIPPINES TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 202 PHILIPPINES IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 PHILIPPINES SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 204 PHILIPPINES CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 205 PHILIPPINES ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 206 PHILIPPINES ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 207 PHILIPPINES DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 208 PHILIPPINES OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 209 PHILIPPINES DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 210 PHILIPPINES VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 211 PHILIPPINES DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 212 PHILIPPINES SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 213 PHILIPPINES DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 214 PHILIPPINES DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 215 PHILIPPINES DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 216 PHILIPPINES HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 PHILIPPINES DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 218 REST OF ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
Lista de Figura
FIGURE 1 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: ASIA-PACIFIC VS REGIONS MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SEGMENTATION
FIGURE 11 TWO SEGMENTS COMPRISE THE ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISION
FIGURE 14 RISING DEMAND FOR EARLY DISEASE DETECTION IS DRIVING THE GROWTH OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET FROM 2024 TO 2031
FIGURE 15 THE MIXERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, 2023
FIGURE 18 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 20 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, 2023
FIGURE 22 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, 2024-2031 (USD THOUSAND)
FIGURE 23 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, CAGR (2024-2031)
FIGURE 24 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, 2023
FIGURE 26 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 27 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 28 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, 2023
FIGURE 30 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, 2024-2031 (USD THOUSAND)
FIGURE 31 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, CAGR (2024-2031)
FIGURE 32 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: BY END USER 2023
FIGURE 34 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 35 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: END USER, CAGR (2024-2031)
FIGURE 36 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET END USER, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 38 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 39 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 40 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SNAPSHOT (2023)
FIGURE 42 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY SHARE 2023 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.